Hubei Honch Pharmaceutical Co., Ltd.

Exhibitor at CPHI Milan 2024 stand 4C110, API
About Us

Hubei Honch Pharmaceutical Co Ltd was established in 2007 and now covers more than 25,000 square meters. We specialize in research, production and sales of anti-tumor APIs and veterinary APIs .

In the field of anti-tumor drugs, we are integrating innovative drugs and generic drugs, such as Ixabepilone, Bortezomib, Vinorelbine Tartrate, etc. Some drugs have got cGMP, CEP and passed international inspection and on-site audit.

In the filed of veterinary drugs, we mainly produce Melbemycine oxime, selamectin and Tulathromycin which are under the process of FDA.

  • CN
  • 2015
    On CPHI since
Company types
Contact info
  • Li shizhen Pharmaceutical Industrial Park, 435300, Hubei, Qichun County, China
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 4C110, API

Products Featured at CPHI Milan 2024